Als Co-Autor mit Prof. Günter Kampf
It was recently described that the overall risk of myopericarditis after receiving a
COVID-19 vaccine is low, except for younger males receiving mRNA vaccines [1]. The
meta-analysis was based on observational studies on people in the general population
who had myopericarditis in temporal relation to receiving vaccines [1]. In order to deter-
mine if these findings were supported by the case numbers in Germany, we evaluated the
number of hospitalised cases, including those receiving intensive-care treatment, with
myocarditis or pericarditis before the pandemic (2019), during the pandemic but without
COVID-19 vaccines (2020), and during the pandemic with COVID-19 vaccines (2021).
Weiterlesen im Journal of Clinical Medicine
Anmerkung: Die Inhalte dieses Beitrags wurden zuvor in einem Beitrag auf Multipolar veröffentlicht.